BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rajbhandari R, Chung RT. Treatment of Hepatitis B: A Concise Review. Clin Transl Gastroenterol 2016;7:e190. [PMID: 27628420 DOI: 10.1038/ctg.2016.46] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Nande A, Hill AL. The risk of drug resistance during long-acting antimicrobial therapy. Proc R Soc B 2022;289. [DOI: 10.1098/rspb.2022.1444] [Reference Citation Analysis]
2 Dekker SE, Green EW, Ahn J. Treatment and Prevention of Acute Hepatitis B Virus. Clin Liver Dis 2021;25:711-24. [PMID: 34593149 DOI: 10.1016/j.cld.2021.06.002] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Nande A, Hill AL. The risk of drug resistance during long-acting antimicrobial therapy.. [DOI: 10.1101/2021.07.10.21260044] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Garcia-Garcia S, Cortese MF, Rodríguez-Algarra F, Tabernero D, Rando-Segura A, Quer J, Buti M, Rodríguez-Frías F. Next-generation sequencing for the diagnosis of hepatitis B: current status and future prospects. Expert Rev Mol Diagn 2021;21:381-96. [PMID: 33880971 DOI: 10.1080/14737159.2021.1913055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Hurwitz SJ, McBrearty N, Arzumanyan A, Bichenkov E, Tao S, Bassit L, Chen Z, Kohler JJ, Amblard F, Feitelson MA, Schinazi RF. Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator. Viruses 2021;13:114. [PMID: 33467678 DOI: 10.3390/v13010114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Lim HK, Jeffrey GP, Ramm GA, Soekmadji C. Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles. Front Cell Infect Microbiol 2020;10:587628. [PMID: 33240824 DOI: 10.3389/fcimb.2020.587628] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
7 Saleem M, Ali S, Khan MB, Amin A, Bilal M, Nawaz H, Hassan M. Optical diagnosis of hepatitis B virus infection in blood plasma using Raman spectroscopy and chemometric techniques. J Raman Spectrosc 2020;51:1067-77. [DOI: 10.1002/jrs.5896] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
8 Kwadzokpui PK, Akorsu EE, Abaka-Yawson A, Quarshie SS, Amankwah SA, Tawiah PA. Prevalence and Knowledge of Hepatitis B Virus Infection among Pregnant Women in the Ningo-Prampram District, Ghana. Int J Hepatol 2020;2020:7965146. [PMID: 32411482 DOI: 10.1155/2020/7965146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Mu T, Zhao X, Zhu Y, Fan H, Tang H. The E3 Ubiquitin Ligase TRIM21 Promotes HBV DNA Polymerase Degradation. Viruses 2020;12:E346. [PMID: 32245233 DOI: 10.3390/v12030346] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
10 Bao CY, Hung HC, Chen YW, Fan CY, Huang CJ, Huang W. Requirement of cyclin-dependent kinase function for hepatitis B virus cccDNA synthesis as measured by digital PCR. Ann Hepatol 2020;19:280-6. [PMID: 31964596 DOI: 10.1016/j.aohep.2019.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Masand VH, El-sayed NNE, Rastija V, Rathore MM, Karnaš M. Identification of prodigious and under-privileged structural features for RG7834 analogs as Hepatitis B virus expression inhibitor. Med Chem Res 2019;28:2270-8. [DOI: 10.1007/s00044-019-02455-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Mathayan M, Jayaraman S, Kulanthaivel L, Suresh A. Inhibition studies of HBV DNA polymerase using seed extracts of Pongamia pinnata. Bioinformation 2019;15:506-12. [PMID: 31485136 DOI: 10.6026/97320630015506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
13 Martin NK, Vickerman P, Khakoo S, Ghosh A, Ramsay M, Hickman M, Williams J, Miners A. Chronic hepatitis B virus case-finding in UK populations born abroad in intermediate or high endemicity countries: an economic evaluation. BMJ Open 2019;9:e030183. [PMID: 31256040 DOI: 10.1136/bmjopen-2019-030183] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Setten RL, Lightfoot HL, Habib NA, Rossi JJ. Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma. Curr Pharm Biotechnol 2018;19:611-21. [PMID: 29886828 DOI: 10.2174/1389201019666180611093428] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
15 Huang SF, Chang IC, Hong CC, Yen TC, Chen CL, Wu CC, Tsai CC, Ho MC, Lee WC, Yu HC, Shen YY, Eng HL, Wang J, Tseng HH, Jeng YM, Yeh CT, Chen CL, Chen PJ, Liaw YF. Metabolic risk factors are associated with non-hepatitis B non-hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B. Hepatol Commun 2018;2:747-59. [PMID: 29881825 DOI: 10.1002/hep4.1182] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
16 Neagu IA, Olejarz J, Freeman M, Rosenbloom DIS, Nowak MA, Hill AL. Life cycle synchronization is a viral drug resistance mechanism. PLoS Comput Biol 2018;14:e1005947. [PMID: 29447150 DOI: 10.1371/journal.pcbi.1005947] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
17 Singh US, Mulamoottil VA, Chu CK. 2′-Fluoro-6′-methylene carbocyclic adenosine and its phosphoramidate prodrug: A novel anti-HBV agent, active against drug-resistant HBV mutants. Med Res Rev 2018;38:977-1002. [DOI: 10.1002/med.21490] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
18 Ghoma Linguissi LS, Nkenfou CN. Epidemiology of viral hepatitis in the Republic of Congo: review. BMC Res Notes 2017;10:665. [PMID: 29197421 DOI: 10.1186/s13104-017-2951-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
19 Daud M, Rana MA, Husnain T, Ijaz B. Modulation of Wnt signaling pathway by hepatitis B virus. Arch Virol. 2017;162:2937-2947. [PMID: 28685286 DOI: 10.1007/s00705-017-3462-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
20 Li Y, Liu Z, Hui L, Liu X, Feng A, Wang W, Zhang L, Li N, Zhou G, Wang Q, Han Q, Lv Y, Wang Q, Yang G, Wang Y. Transbody against virus core protein potently inhibits hepadnavirus replication in vivo: evidence from a duck model of hepatitis B virus. Br J Pharmacol 2017;174:2261-72. [PMID: 28383135 DOI: 10.1111/bph.13811] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]